Vinva Investment Management »

Travere Therapeutics shares owned by Vinva Investment Management

Quarter-by-quarter ownership of Travere Therapeutics (TVTX) shares owned by Vinva Investment Management from 13F filings

Historical chart of Vinva Investment Management investment in Travere Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Travere Therapeutics held by Vinva Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Travere Therapeutics by Vinva Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $621k 15k 40.35

More positions owned by Vinva Investment Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Colgate-Palmolive Company (CL)
Eli Lilly & Co. (LLY)
Msci (MSCI)
Tapestry (TPR)
Visa Com Cl A (V)

View all positions for Vinva Investment Management

Top funds holding Travere Therapeutics

Henderson Group
FMR
BlackRock
Vanguard Group
State Street Corporation
Armistice Capital
Perceptive Advisors
Vanguard Capital Management
Nomura Asset Management International
Kynam Capital Management
Geode Capital Management
Renaissance Technologies
Stephens Investment Management Group
Goldman Sachs Group
Vanguard Portfolio Management

View all funds holding Travere Therapeutics